Novo Nordisk A/S

NVON.MX·Mexico·Healthcare
Compare
716.09−7.07 (−0.98%)today
At close: Oct 16, 1:57 PM CST · May be delayed up to 20 min · MXN

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close723.16
Open726.00
Day range715.50726.00
52-week range637.431,119.03
Off day high−1.37%
Off 52-week high−36.01%
Volume1.63K
Avg. volume (3M)6.82K
Market cap3.16T
EPS (TTM)73.61
Forward P/E—
P/E ratio (TTM)9.73
Dividend yield4.35% (31.15)
Beta (5Y)0.38
Shares outstanding3.34B
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin35.35%

Against its peers

Compare in full ›
NVON.MX LLY NVS JNJ AZN MRK
Market cap 3.16T 1.12T 286.29B 615.87B 256.54B 360.08B
P/E (TTM) 9.7 42.2 22.8 38.8 23.8 115.8
Forward P/E — 26.6 15.4 21.8 14.6 15.7
Price/book 5.3 33.1 6.9 7.2 5.1 8.6
Dividend yield 4.35% 0.55% 3.15% 2.10% 1.94% 2.33%
1-year change −29.79% +55.39% +14.29% +31.92% −1.39% +69.08%
Today −0.98% +0.43% +0.16% +0.90% −0.76% +0.52%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Latest news

All NVON.MX news ›
The Manila Times·Positive

Novo Nordisk A/S - share repurchase programme

Under the programme initiated 6 May 2026, Novo Nordisk will repurchase B shares for an amount up to DKK 11,200,000,010.45 in the period from 6 May 2026 to 1 February 2027. Since the announcement 5 October, the following transactions have…

MarketScreener·

Novo Nordisk A/S : Insider Transactions

Follow insider transactions on Novo Nordisk A/S in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Novo Nordisk A/S Latest insider transactions for Novo Nordisk A/S All…

MarketScreener·Negative

Novo Nordisk A/S : JP Morgan is Neutral

Published on 10/05/2026 at 07:45 am EDT Novo Nordisk and Eli Lilly trade blows September 29, 2026 at 09:34 am EDT Novo Nordisk: Aiming below the mark Novo Sues Rival Lilly Over Weight-Loss Ads

MarketScreener·Positive

Novo Nordisk A/S: Relative Strength Chart - Stock Nasdaq Copenhagen

Compare Novo Nordisk A/S with the company of your choice via a Relative Strength chart. Real-time NOVO B price, Nasdaq Copenhagen stock exchange Relative Strength Chart Novo Nordisk A/S All financial news and data tailored to specific…

MarketScreener·Negative

Novo Nordisk A/S : Deutsche Bank gives a Sell rating

Published on 10/07/2026 at 03:28 am EDT Novo Nordisk and Eli Lilly trade blows September 29, 2026 at 09:34 am EDT Novo Nordisk: Aiming below the mark Novo Sues Rival Lilly Over Weight-Loss Ads

MarketScreener·Negative

Novo Nordisk A/S: Official Announcements - Stock Market News

Novo Nordisk and Eli Lilly trade blows September 29, 2026 at 09:34 am EDT Novo Nordisk: Aiming below the mark Novo Sues Rival Lilly Over Weight-Loss Ads GLP-1: The Winners and Losers of Shifting Consumer Habits

From articles in the 4Search news index.

In the news

24mentions in 30 days
24with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.